In conclusion, the results of the present study describe a new indirect role played by PCSK9 in atheroma formation by providing new evidence to the hypothesis that PCSK9 is involved in the pathogenesis of cardiovascular disease, independent of hyperlipidaemia but possibly by fuelling a pro-inflammatory feed-forward-loop. This evidence concerns the gene PCSK9 and hyperlipidemia.